Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry.
Br J Dermatol. 2022 Dec;187(6):1022-1024. doi: 10.1111/bjd.21794. Epub 2022 Sep 6.
Br J Dermatol. 2022.
PMID: 35895855
Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry.
Traidl S, Heinrich L, Siegels D, Heratizadeh A, Kind B, Haufe E, Abraham S, Schäfer T, Augustin M, Harder I, Pinter A, Schäkel K, Wollenberg A, Ertner K, Ramaker-Brunke J, Bong A, Quist S, Gorriahn-Maiterth H, Schenck F, Sticherling M, Effendy I, Schwarz B, Handrick C, Asmussen A, Weidinger S, Schmitt J, Werfel T; TREATgermany study group.
Traidl S, et al.
J Eur Acad Dermatol Venereol. 2024 Mar 28. doi: 10.1111/jdv.19979. Online ahead of print.
J Eur Acad Dermatol Venereol. 2024.
PMID: 38545850
No abstract available.
Item in Clipboard
Cite
Cite